ClinicalTrials.gg
Not yet recruitingNCT06348810DTTUpdated May 29, 2024

Dual-Task Training for People With Mild Cognitive Impairment and Mild Dementia

An interventional study of Dual-task training and Cognitive training in Dementia, Mild Cognitive Impairment and Older Adult, sponsored by Taipei Medical University. Not yet recruiting at 1 site in Indonesia. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-29.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Evidence shows that people with dementia have a higher prevalence of sleep disturbance, cognitive decline, behavioral disturbance, and experience motor dysfunction. These symptoms are interrelated. However, few randomized controlled trial (RCT) studies implement dual-task training for mild cognitive impairment and mild dementia, especially for those who experience sleep problems and behavioral disturbances.

Therefore, this study aims to analyze the effect of dual-task training in improving global cognitive function, executive function, working memory, sleep, behavioral disturbances, balance, and flexibility among people with mild cognitive impairment and mild dementia.

The main questions it aims to answer are:

  1. . Does dual-task training affect primary outcomes (global cognitive function, executive function, and working memory)
  2. . Does dual-task training affect secondary outcomes (including sleep quality, behavioral disturbances, balance, and flexibility) for people with mild cognitive impairment and mild dementia?"

The length of dual-task training is 12 weeks; sessions are 3 times per week, each session lasts 45 minutes, and total sessions are 36. There are three groups of intervention (dual-task training, cognitive training, and motor training). While the control group receives the usual care. Researchers will compare the experiment and control groups to see the effect of the dual-task training.

Read the detailed description

Sample size calculation: Investigators use the G*Power sample size calculator under an F test with an analysis of variance based on some criteria, for instance: effect size 0.2 (small), power 80%, four times measurement, four groups (cognitive training, motor training, dual-task training, and control group) and α error probability of 0.05. The sample size from the calculator yields 48 in total, considering 50% attrition rate, finally 72 participants (18 participants for each group) will be recruited.

Sample recruitment: Investigator will use a CONSORT flow diagram to describe the phases of this study. A purposive sampling technique will be used in this study to specifically select the nursing home. Following this, eligibility interviews and screening test using MMSE (The Mini Mental State Examination) and The Clinical Dementia Rating (CDR) will be used to recruit participants. The participants will be recruited in this study CDR score varies from 1 to 4, and MMSE >=18. Other inclusion criteria are complain of conscious cognitive decline, participate voluntarily and sign informed consent. However, potential participants will be excluded if they diagnosed with moderate or severe dementia, those who have received cognitive training or motor training within six months, people with severe sensory function impairment (such as vision, hearing), and with limited mobility, such as those using wheelchairs or four-legged walking aids.

Randomization and Blinding: The allocation of the group to be either the experimental (dual-task training group, cognitive training group, motor training group) or control group will be conducted using permuted block randomization design with a block size of four. Randomization was carried out using a web-based randomization tool by a third party who was not involved in the intervention team. To ensure the allocation concealment, investigators use SNOSE principle (sequentially numbered, opaque, sealed envelopes), and randomization code will not be released until the participant or interventionist has started the trial. This study adopts a single-blind approach, by blinding data collector.

Baseline Data Collection Procedure: Participants who meet the inclusion criteria and agree to participate, will be requested to complete a sociodemographic characteristic questionnaire and the seven outcome measures. However, the completion of the seven outcome measures will be conducted in two days to avoid boredom among the participants. In the first period, a sociodemographic questionnaire, WCST, DS, NPI-Q will be completed. The PSQI, ISI, SFBBS, Chair sit-and-reach test (CSR) and Back scratch test completion will be conducted later in the second day at a time agreed upon by the researcher and participants.

Intervention delivery: 1). The dual-task training is a combination of cognitive tasks and motor tasks. Motor task consist of six components, including: strength, balance, agility, gait, aerobic capacity, and flexibility. Whereas Cognitive task consists of four cognitive domains: attention, executive function, learning and memory, language, and perception motor. Both component will be delivered simultaneously or at the same time, and will be delivered in a group format, consisting of 8 to 10 participants for each group. The length of therapy is 12 weeks; sessions are 3 times per week, each session lasts 45 minutes (20 minutes first: cognitive tasks and motor tasks, 5 minutes break time (at this time, participants will be given drink and snack), 20 minutes second: cognitive tasks and motor tasks), and total sessions are 36. In this study, only one interventionist (the principal investigator) from the research team will deliver the intervention sessions. The detail description of each session are below: session 1-6: Participants initially receive one of two tasks (either a cognitive or motor task) and undergo training for each individually; session 7-12: participants receive cognitive and motor task at the same time; session 13-18: repetition of sessions 7 to 12, and session 19-36 are repetition from session 1 to 18. 2). Cognitive training= in this group, participants only receive cognitive training. 3). Motor training= in this group, participants only receive motor training. The duration are same with dual-task training.

Outcomes: The primary outcomes of this study are global cognitive function, executive function, and working memory. Global cognitive is measured using MMSE that consists of five domains. MMSE 0-17 scores indicating severe cognitive impairment, 18-23 mild cognitive impairment, and 24-30 as normal (no cognitive impairment). MMSE was valid and had reliability of 0.763. Executive function in this study will measure using the Wisconsin card sort test (WCST), which has satisfactory reliability and validity for measuring executive function, possessing a split-half reliability of 0.89-0.93 for older adults and test-retest reliability of 0.76. Working memory is measured using a Digit span (DS) test that comprises both digit forward (16 points) and digit backward (14 points). The secondary outcomes of this study are sleep quality, behavioral disturbance, balance, and flexibility. Sleep quality is measured using the Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI). Behavioral disturbance will be assessed with the Neuropsychiatric Inventory-Questionnaire (NPI-Q). Balance is measured with the Short Form Berg Balance Scale (SFBBS), and flexibilty using flexibility using the Chair sit-and-reach test (CSR) and Back scratch test.

Post-test and Follow-up Data Collection Procedure Participants will be requested to complete questionnares consist of: MMSE, WCST, DS, PSQI, ISI, NPI-Q, SFBBS, Chair sit-and-reach test (CSR) and Back scratch test, in the middle session of the intervention (week 6, after session 18), after intervention completed (week 12, 1 month follow-up time (week 16, measured from baseline)

Statistical analysis: The collected data will be analyzed using IBM SPSS for Windows version 23 and assumed a statistical significance level of p ≤ 0.05. Data consistency checks will be conducted to verify the reliability of the data collected. Descriptive statistics (frequency, percentage, mean, and standard deviation) will be used to summarize the characteristics of the participants and the outcomes. To compare the baseline group differences, investigators will use Chi-square or Fisher exact tests for categorical data, and independent t-tests for continuous data with normal distribution. The generalized estimating equation (GEE) test is used for analyze main outcome with follow the intention-to-treat (ITT) analysis principle, and this test can handle missing data, so no need imputation for missing data.

Interim Analysis and Stopping Guideline: During the study and subsequent follow-up data collection, investigators do not expect any issues that would be harmful to the participants. Investigators have no established termination criteria, and investigators do not plan to perform interim analyses before the follow-up data collection is completed.

02

Conditions studied

  • Dementia
  • Mild Cognitive Impairment
  • Older Adult

Keywords

  • dual-task training
  • Dementia
  • Mild Cognitive Impairment
  • Older adult
  • Sleep quality
  • behavioral disturbance
  • cognition
  • balance
  • flexibility
03

In context

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

This study's planned enrollment of 72 is below the median of 90 across 1,761 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Taipei Medical University is the lead sponsor of 258 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adult >= 60 years and able to communicate
  • CDR score range from 1 to 4
  • score >= 18
  • Complain of conscious cognitive decline.
  • Participate voluntarily and sign .

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with moderate or severe dementia.
  • Received cognitive training or motor training within six months.
  • Severe sensory function impairment (such as vision, and hearing).
  • Have limited mobility, such as those using wheelchairs or four-legged walking aids.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Dual-task training

    Participants in the experimental group will receive dual-task training, which consists of cognitive and motor task carried out at the same time. The length of therapy is 12 weeks; sessions are 3 times per week, each session lasts 45 minutes, and total sessions are 36.

    Behavioral: Dual-task training

  • Experimental
    Cognitive training

    Participants in this group receive cognitive training only. The length of therapy is 12 weeks; sessions are 3 times per week, each session lasts 45 minutes, and total sessions are 36.

    Behavioral: Cognitive training

  • Experimental
    Motor training

    Participants in this group receive motor training only. The length of therapy is 12 weeks; sessions are 3 times per week, each session lasts 45 minutes, and total sessions are 36.

    Behavioral: Motor training

  • Active comparator
    Usual

    Participants in this group receive usual care provided by the nursing home staff, which typically includes assistance with activities of daily living, medication management, and social activities. They do not receive the structured physical exercise program.

    Other: Usual care

Interventions

  • BehavioralDual-task training

    The dual-task training is a combination of cognitive tasks and motor tasks which is done simultaneously or at the same time.

    Also known as: combination of motor and cognitive task

  • BehavioralCognitive training

    Participants only receive cognitive tasks

  • BehavioralMotor training

    Participants only receive motor tasks

  • OtherUsual care

    assist participants with activities of daily living, medication management, and social activities (such as singing, watching television).

    Also known as: Routine care

06

What researchers measure

Primary outcomes

  1. Global cognitive function

    measured using MMSE that consists of five domains including orientation to time (5 points), orientation to place (5 points), registration (3 points), attention and calculation (5 points), recall (3 points), and language (9 points), ranges from 0 to 30. MMSE 0-17 scores indicating severe cognitive impairment, 18-23 mild cognitive impairment, and 24-30 as normal (no cognitive impairment).

    Time frame: baseline, week 6, week 12, week 16

  2. Executive function

    measured with the Wisconsin card sort test (WCST). The result of the test is then categorized including: 1). number of completed categories (NCC), 2). total number of errors, 3). perseverative response (PR), 4). perseverative errors, 5). non-perseverative errors (NEs), 6). conceptual level responses (CLRs), 7). failure to maintain set, and 8). trials to complete the first category

    Time frame: baseline, week 6, week 12, week 16

  3. Working memory

    measured using a Digit span (DS) test that comprises both digit forward (16 points) and digit backward (14 points). In the DS forward, the participant had to listen to a digit span that kept to the speed of one digit per second and repeat it forward. In contrast, to DS forward, in the DS backward, the participant had to listen and repeat the span backward. Span was taken as the maximum length if performed without error. However, if participants answered wrong 2 times consequently, the task ended and the number of correct answers was calculated as a score

    Time frame: baseline, week 6, week 12, week 16

Secondary outcomes

  1. Sleep Quality

    Sleep Quality is measured using two instruments. First: Pittsburgh Sleep Quality Index (PSQI). This instrument consists of a 19-item self-rated questionnaire to assess sleep quality during the last month, which includes seven domains, i.e., subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The score for each domain ranges from 0 to 3, and the total PSQI score ranges from 0 to 21. PSQI score of \> 5 indicate poor sleep quality. Second: Insomnia Severity Index (ISI). The insomnia severity index is a 7-item self-report questionnaire assessing insomnia's nature, severity, and impact in the past two weeks. The total score is interpreted as follows: absence of insomnia (0-7), sub-threshold insomnia (8-14), moderate insomnia (15-21), and severe insomnia (22-28)

    Time frame: baseline, week 6, week 12, week 16

  2. Behavioral disturbance

    Behavioral disturbance, also known as behavioral and psychological symptoms of dementia (BPSD) or neuropsychiatric symptoms. Behavioral disturbances can be grouped into four categories: mood disorders (such as depression, anxiety, apathy, and euphoria); sleep disorders (such as insomnia, hypersomnia, and night-day reversal); psychotic symptoms (such as hallucinations and delusions); and agitation (such as pacing, wandering, sexual disinhibition, and aggression). Behavioral disturbance will be assessed using the Neuropsychiatric Inventory-Questionnaire (NPI-Q). A higher score pointed to higher severity of neuropsychiatric symptoms (NPS).

    Time frame: baseline, week 6, week 12, week 16

  3. Balance

    measured using the Short Form Berg Balance Scale (SFBBS). Total score varies from 0 to 14. Higher scores indicate better balance and lower risk of falling

    Time frame: baseline, week 6, week 12, week 16

  4. Flexibility

    Flexibility is measured through two ways. The first test is the Chair sit-and-reach test (CSR). CSR is used to measure hamstring flexibility. Participants were instructed to reach down the extended leg in an attempt to touch the toes. The middle of the toe at the end of the shoe represented a "zero" score. Reaches short of the toes were recorded as minus scores, and reaches beyond the toes were recorded as plus scores. The second test is Back scratch test, used to measure upper body and shoulder flexibility. The participants started the test by standing upright, placing one arm/hand on the lower back, and moving it up the spine toward their head. The gap between the fingertips of the long fingers of both hands was measured to the nearest half cm. The results were recorded in the nearest half cm, as back scratch right arm and left arm over, with positive numbers as long as the fingers overlapped and with negative numbers if the fingers did not meet.

    Time frame: baseline, week 6, week 12, week 16

07

Study locations

1 site
  • Nursing Home
    Malang, Jawa Timur 65216, Indonesia
08

References and documents

Publications

  • Baltaci G, Un N, Tunay V, Besler A, Gerceker S. Comparison of three different sit and reach tests for measurement of hamstring flexibility in female university students. Br J Sports Med. 2003 Feb;37(1):59-61. doi: 10.1136/bjsm.37.1.59. PubMed 12547745 ↗
  • Abbas-Zadeh M, Hossein-Zadeh GA, Vaziri-Pashkam M. Dual-Task Interference in a Simulated Driving Environment: Serial or Parallel Processing? Front Psychol. 2021 Jan 12;11:579876. doi: 10.3389/fpsyg.2020.579876. eCollection 2020. PubMed 33584415 ↗
  • Ambrogio F, Martella LA, Odetti P, Monacelli F. Behavioral Disturbances in Dementia and Beyond: Time for a New Conceptual Frame? Int J Mol Sci. 2019 Jul 25;20(15):3647. doi: 10.3390/ijms20153647. PubMed 31349706 ↗
  • Bayot M, Dujardin K, Tard C, Defebvre L, Bonnet CT, Allart E, Delval A. The interaction between cognition and motor control: A theoretical framework for dual-task interference effects on posture, gait initiation, gait and turning. Neurophysiol Clin. 2018 Dec;48(6):361-375. doi: 10.1016/j.neucli.2018.10.003. Epub 2018 Oct 26. PubMed 30487064 ↗
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4. PubMed 2748771 ↗
  • Chiu HL, Chan PT, Kao CC, Chu H, Chang PC, Hsiao SS, Liu D, Chang WC, Chou KR. Effectiveness of executive function training on mental set shifting, working memory and inhibition in healthy older adults: A double-blind randomized controlled trials. J Adv Nurs. 2018 May;74(5):1099-1113. doi: 10.1111/jan.13519. Epub 2018 Jan 24. Erratum In: J Adv Nurs. 2020 Nov;76(11):3213. doi: 10.1111/jan.14529. PubMed 29288507 ↗
  • Kuan YC, Huang LK, Wang YH, Hu CJ, Tseng IJ, Chen HC, Lin LF. Balance and gait performance in older adults with early-stage cognitive impairment. Eur J Phys Rehabil Med. 2021 Aug;57(4):560-567. doi: 10.23736/S1973-9087.20.06550-8. Epub 2020 Dec 1. PubMed 33258361 ↗
  • Tzeng RC, Yang YW, Hsu KC, Chang HT, Chiu PY. Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages. Front Aging Neurosci. 2022 Sep 23;14:1021792. doi: 10.3389/fnagi.2022.1021792. eCollection 2022. PubMed 36212036 ↗
  • Yang HL, Chu H, Kao CC, Chiu HL, Tseng IJ, Tseng P, Chou KR. Development and effectiveness of virtual interactive working memory training for older people with mild cognitive impairment: a single-blind randomised controlled trial. Age Ageing. 2019 Jul 1;48(4):519-525. doi: 10.1093/ageing/afz029. PubMed 30989165 ↗
  • Musa G, Henriquez F, Munoz-Neira C, Delgado C, Lillo P, Slachevsky A. Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile. Dement Neuropsychol. 2017 Apr-Jun;11(2):129-136. doi: 10.1590/1980-57642016dn11-020005. PubMed 29213504 ↗

Individual participant data

Plan to share: Yes — Particular data will be shared: Individual participant data that underlie the results reported in this article, after identification (text, tables, figures, and appendices).

Supporting information: Study protocol

Time frame: Beginning 6 months and ending 36 months following article publication.

Access criteria: Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2024; primary completion for Dec 2024, 5 months later.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 5 months is below that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2024
First posted
Apr 5, 2024
StartEst.
Jul 1, 2024
Primary completionEst.
Dec 30, 2024
CompletionEst.
Dec 30, 2024
Last update
May 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06348810
Responsible party
Nur Aini (MSc, Taipei Medical University) — Principal investigator
First posted
Apr 5, 2024
Start date
Jul 1, 2024 (estimated)
Primary completion
Dec 30, 2024 (estimated)
Completion
Dec 30, 2024 (estimated)
Last update
May 29, 2024

Study contacts

Nur Aini, MSc
Contact
d432110003@tmu.edu.tw
+6285234727354
Nur Aini, MSc
principal investigator · School of Nursing, College of Nursing, Taipei Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion